Beranda › Kanker Paru Non-Sel Kecil › Florida › Sarasota
Uji klinis Kanker Paru Non-Sel Kecil di Sarasota, FL
17 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Sarasota (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Menerima pesertaFase 1
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Menerima pesertaFase 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Menerima pesertaFase 2/3
- Local Institution - 007-922-I, Sarasota
- Local Institution - 007-922-J, Sarasota
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Menerima pesertaFase 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Florida Cancer Specalists, Sarasota
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Menerima pesertaFase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Menerima pesertaFase 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
Menerima pesertaFase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Menerima pesertaFase 1
- Florida Cancer Specialists, Sarasota
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Menerima pesertaFase 1
- Florida Cancer Specialists, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- Florida Cancer Specialists, Sarasota
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Menerima pesertaFase 1
- Dren Investigational Site, Sarasota
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Sarasota
- Kanker Metastatik19 studi
- Kanker Kolorektal16 studi
- Kanker Ovarium16 studi
- Kanker Endometrium14 studi
- Kanker Payudara12 studi
- Kanker (semua jenis)11 studi
- Kanker Payudara Triple-Negatif8 studi
- Kanker Paru7 studi
- Kanker Pankreas7 studi
- Fibrilasi Atrium7 studi
- Kanker Prostat6 studi
- Penyakit Hati Steatotik6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.